🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Illinois › Evanston

Non-Small Cell Lung Cancer clinical trials in Evanston, IL

22 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Evanston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RecruitingPhase 3
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi away
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RecruitingPhase 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06498635

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RecruitingPhase 3
  • Illinois Cancer Specialists, Niles · 6 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

RecruitingPhase 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06758401

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

RecruitingPhase 3
  • Clinical Study Site, Evanston
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

RecruitingPhase 2/3
  • USOR - Illinois Cancer Specialists - Niles, Niles · 6 mi away
  • Advocate Medical Group Oncology, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT04613596

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

RecruitingObservational study
  • Orchard Healthcare Research Inc., Skokie · 2 mi away
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT05935384

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

RecruitingPhase 3
  • Research Site, Niles · 6 mi away
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07291037

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

RecruitingPhase 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06686771

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

RecruitingPhase 2
  • Advocate Aurora Health, Park Ridge · 8 mi away
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2/3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi away
18 Minutes · All sexes · Updated May 5, 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RecruitingObservational study
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi away
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

RecruitingObservational study
  • Northwestern University, Evanston
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114

Non-Small Cell Lung Cancer trials in other cities

Other studies in Evanston

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.